Static and repeated accommodation both significantly reduce IOP

Article

Both static and repeated accommodation significantly reduce intraocular pressure (IOP).

Both static and repeated accommodation significantly reduce intraocular pressure (IOP), reveals a paper in the Journal of Glaucoma.

Dr Frank Jenssen et al., Department of Ophthalmology, Haukeland University Hospital, Bergen, Norway, included 33 healthy participants aged 20 to 29 years in a randomized, single-blind study.

After viewing a target in the distance for 10 minutes baseline IOP was measured. Participants focused on a near target for three minutes to achieve static accommodation. Volunteers were also asked to alternate their focus on near and distant targets for three minutes to achieve repeated accommodation.

An infrared photoreceptor was used to continuously monitor accommodative responses and Goldmann tonometry was conducted straight after the accommodative process.

After static accommodation IOP was 13.4±2.4 mmHg and for repeated accommodation it was 12.7±2.3 mmHg. This demonstrated a mean change in IOP of −1.76±1.17 mmHg and −2.06±1.48 mmHg, for static and repeated accommodation respectively. Although the drop was greater in repeated accommodation than static, the difference was not statistically significant.

The investigation suggests that aqueous humour outflow isn't strongly influenced by recurrent ciliary muscle contractions.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.